Glyceryl trinitrate is used under the tongue for the rapid relief of angina pectoris. Ideally, the tablets are rapidly absorbed and take effect in one to two minutes. It is well known that glyceryl trinitrate is unstable and that the tablets should be protected from light and extremes of heat and stored in glass bottles that do not contain cotton wool or other packing material.1 2Although the tablets are supplied by the manufacturers in suitable containers, they are often stored under less than ideal conditions after leaving the manufacturer. We investigated whether loss of activity of glyceryl trinitrate occurred owing to poor storage by patients.
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Methods
Twenty-one consecutive patients who attended a cardiac clinic and were taking glyceryl trinitrate for angina were interviewed and asked for a sample of their tablets. They were asked about the duration of storage of the tablets since dispensing, the normal place of storage, how often they took tablets, and whether the tablets were effective. In addition, the type of container, the presence and type of packing material, and the number of tablets remaining were recorded. After collection from patients the tablets were stored below 250 in individual dark glass bottles without any packing material. Eleven tablets were chosen using tables of random numbers and one each given to 11 healthy volunteers aged 20 to 29 years (mean 22-9 years). Each volunteer also received on different days a placebo tablet and a fresh tablet from a previously unopened manufacturer's container. The doses were given in random order and using a double-blind design. The heart rates and blood pressures of the volunteers were measured three times before the tablet was taken to establish a steady baseline. Measurements were also taken as the tablet was given and at intervals of 2, 4, 6, 8, 10, 15, 20, 25, 30, 40, 50, and 60 Some patients took tablets regularly-for example, several times a week-whereas others only occasionally used them. The mean increase in heart rate produced at the various time intervals by each of the tablets is shown in the figure. The 60 Minutes atter dose Mean (±SEM) increase in heart rate of 11 volunteers at 2, 4, 6, 8, 10, 15, 20, 25, 30, 40, 50 , and 60 minutes after taking glyceryl trinitrate.
difference between the increase in heart rate caused by the fresh tablets and the increase caused by placebo was significant at aU times up to 20 minutes (p < 0.02). Significant differences (p < 0 05 or less) between the patients' tablets and placebo occurred at most, but not all, times up to 15 minutes. The areas under the heart rate-time curves for fresh tablets and patients' tablets were estimated from the time of drug administration for 15, 20, and 30 minutes, and the difference between tablets was significant in each case (p < 0-02). Fresh tablets and those returned by patients could not be distinguished on the basis of symptoms reported by volunteers.
Discussion
The decreased activity of the patients' tablets compared with fresh tablets showed that storage by patients had an adverse effect on the quality of tablets. The increase in heart rate caused by the patients' tablets at 10 minutes was less than half that produced by the fresh tablets, and after 15 minutes the patients' tablets did not produce an effect that was significantly different from placebo. The fresh tablets continued to cause an appreciable increase in heart rate until 20 minutes after administration, and an overall difference in effect (area under the curve) could be observed up to 30 minutes after administration.
Despite the inclusion of stabilisers in recent formulations of glyceryl trinitrate tablets,3-5 maintaining stability during use is still a problem. The importance of proper storage is well known medically, but clearly there is a failure in communication between doctor and patient since most patients normally stored their full supply of tablets for long periods under inappropriate conditions. Only two patients produced the recommended type of container, and one of these contained absorbent packing material. Though it is necessary for patients to carry a supply of tablets with them, they should be encouraged to carry only a small number of tablets in this way and to store the remaining tablets at home under the recommended conditions. We therefore recommend that greater care should be taken in dispensing glyceryl trinitrate tablets to ensure that the containers conform to the manufacturer's recommendations. The number of tablets prescribed at one time should be related to likely consumption, and care should be taken to ensure that patients understand the importance of proper storage. From the question, it seems likely that this woman had severe hyperparathyroid bone disease. Postoperatively, the serum calcium concentration almost invariably falls because of the "hungry bone" syndrome. This is due to rapid repair of the bone disease with a high influx of calcium into the skeleton. Vitamin D is almost always needed in severe cases in addition to calcium supplements. A convenient form of treatment would be to give 1 to 2 micrograms of 1,25 dihydroxy vitamin D (Rocaltriol) or 1 alpha hydroxy vitamin D (1 alpha) together with four to eight tablets of calcium supplements. Often high doses of calcium supplements give diarrhoea. The requirements for vitamin D and calcium supplements lasts for about a month, after which treatment can be slowly withdrawn over the course of a few weeks provided that normocalcaemia is maintained. If hypocalcaemia recurs as a long-term problem this suggests that the patient has postsurgical hypoparathyroidism, in which case the need for vitamin D supplements is likely to be permanent.-D J HOSKING, senior lecturer in medicine, Nottingham. Yes. The active ingredient in proprietary remedies for restoring colour to grey hair is either a metallic salt, usually lead acetate, or a synthetic dye of the paraphenylene diamine series. Metallic salts work by forming a film on the surface of the hair that produces a gradual darkening of the hair as the layers build up; paraphenylene diamine dyes infiltrate the shaft of the hair itself and produce a rapid and permanent darkening. The lead is present in only small quantities and provided it stays on the hair is unlikely to be hazardous to health, but it is unwise to apply it to facial hair near the mouth or to hair on damaged or diseased skin as absorption is possible. Metallic dye products are popular at the moment and, sadly, many lead-containing products are not labelled with their constituents or with adequate warnings. In view of the current concern about the lead in our environment it seems unnecessary to permit this use of lead when other dyes are effective. Paraphenylene diamine dyes do induce contact hypersensitivity in a few otherwise normal individuals, but the risk is small. Other ingredients, such as the vehicle, may also contain potential allergens and even primary irritants, but their hazard is likewise small. -A B SHRANK, consultant dermatologist, Shrewsbury.
Cronin E. Contact dermatitis. London: Churchill Livingstone, 1980:115-26. A young woman had severe bronchitis after which she claims that everything smells bad. During the attack of bronchitis she temporarily lost her sense of smell. What might be the cause of her complaint and what treatment is advised?
